A possible interaction of quipazine with central dopamine structures.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D003533:Cyproheptadine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010868:Pimozide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D000928:Antidepressive Agents; D010879:Piperazines; D011804:Quinolines; D010868:Pimozide; D003533:Cyproheptadine; D012110:Reserpine; D006220:Haloperidol; D004298:Dopamine; D008784:Methysergide